Fall 2025 Seminar Series
TPRI’s Fall 2025 Works-in-Progress Workshop Series is on Wednesdays at 11:00 a.m. – 12:00 p.m. (ET) via Zoom. The Spring 2026 Series will resume on January 28 until May 6, 2026. For consideration, please see the call for abstracts on the TPRI home page or subscribe to the newsletter to receive future calls.
Fall 2025 Seminar Series Schedule:
September 10: John McKeon, Boston University Questrom School of Business, “Should I Stay or Should I Go: Startup Repositioning Following Rival Acquisitions”
September 17: James Bessen, BU, TPRI, “Is R&D Rivalry Slowing the Growth of Productive Firms?”
September 24: Justine Boudou, Harvard Business School, “Not All That Glitters is Gold: Firm Hiring in the Market for Knowledge Workers”
October 1: Matt Marx, Cornell/NBER, “Connecting Fundamental Science to Commercial Innovation: A Public Dataset of Patent-Paper Pairs”
October 8: Anne Marie Knott, Washington University, St. Louis, “Lifting the Burden of Knowledge ”
October 15: Georgios Petropoulos, USC Marshall School of Business and CESifo, Los Angeles, CA, “Assessing the Impact of Algorithmic Quantity Regulations on Sharing Platforms: Evidence from Airbnb in Paris”
October 22: John M. Golden, The University of Texas at Austin School of Law, “Nonobviousness and Analogous Arts”
October 29: Sojun Park, MIT, “Innovation, Imitation, and Political Cleavages in International Trade and Patent Protection”
November 5: Olivia Zhao, Harvard Business School, “Policy Incentives for Pharmaceutical Innovation”
November 12: Jun Oh, Purdue University, “Interlocking Directors and Technology Foreclosure of Peer Firms: Evidence from Licensing Agreements”
November 19: Remziye Zaim, University of Toronto, “Artificial Intelligence Software as a Medical Device: Regulatory Approvals and Post-Deployment Evaluation Frameworks in North America and Europe”
December 3: Yifan Tian, Bocconi University, “Job Displacement and Worker Productivity: Evidence from Mass Layoffs in the United States”
December 10: Fabian Gaessler, Pompeu Fabra University, “Limits to the Division of Innovative Labor: Evidence from the Pharmaceutical Industry”